INFU vs TBRG
INFU: InfuSystem is a specialized provider of durable medical equipment and managed healthcare services that enables the seamless transition of oncology and other infusion therapies from clinical settings to the home. TBRG: TruBridge provides revenue cycle management and electronic health record solutions to community hospitals and healthcare systems seeking to optimize financial and clinical operations.
Side-by-side fundamentals
| Metric | INFU | TBRG | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $9.36 | $26.24 | |
| Market cap as of 2026-07-30 | $200M | $394M | |
| P/E as of 2026-07-30 | 25.31 | 89.43 | INFU lower |
| PEG as of 2026-07-30 | 0.17 | 1.18 | INFU lower |
| Net margin as of 2026-07-30 | +5.6% | +1.3% | INFU higher |
| Gross margin as of 2026-07-30 | +56.8% | +53.2% | INFU higher |
| Operating margin as of 2026-07-30 | +9.1% | +4.5% | INFU higher |
| ROE as of 2026-07-30 | +14.0% | +2.5% | INFU higher |
| ROA as of 2026-07-30 | +7.9% | +1.1% | INFU higher |
| Debt / equity as of 2026-07-30 | 0.33 | 0.92 | INFU lower |
| Revenue growth (YoY) as of 2026-07-30 | +3.5% | -0.2% | INFU higher |
| Revenue CAGR (3y) SEC XBRL | +9.3% | +2.0% | INFU higher |
| Beta as of 2026-07-30 | 1.48 | 1.28 | |
| 1-year return as of 2026-07-27 close | +55.7% | +18.9% | INFU higher |
Fundamentals: market data, as of 2026-07-30. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.